LG launches home-grown diabetes treatment

Published: 2012-12-04 06:56:00

Updated: 2012-12-04 06:56:00

LG Life Sciences (LGLS) said Monday that it has launched Gemiglo (gemigliptin) here, which is effective on type-2 diabetes patients, who have a high blood sugar level though their insulin secretion is working.

Gemiglo, the main substance of which is gemigliptin, is the 19th new drug developed ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK